Click for best price
Human Gene Therapy Market Size, Share 2023
Gene therapy is?a medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.
This report aims to provide a comprehensive presentation of the global market for Human Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Gene Therapy. This report contains market size and forecasts of Human Gene Therapy in global, including the following market information:
Global Human Gene Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Gene Therapy Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Gene Therapy companies in 2022 (%)
The global Human Gene Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-viral Vectors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Gene Therapy include Biogen, Sarepta Therapeutics, Gilead Sciences, Amgen, Novartis, Orchard Therapeutics, Spark Therapeutics, Agc Biologics and Anges, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Gene Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Gene Therapy Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Non-viral Vectors
Viral Vectors
Global Human Gene Therapy Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others
Global Human Gene Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Gene Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Gene Therapy revenues share in global market, 2022 (%)
Key companies Human Gene Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Gene Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Gene Therapy, market overview.
Chapter 2: Global Human Gene Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Human Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Gene Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Gene Therapy Market Professional Survey, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Gene Therapy Overall Market Size
2.1 Global Human Gene Therapy Market Size: 2022 VS 2029
2.2 Global Human Gene Therapy Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Gene Therapy Sales: 2018-2029
3 Company Landscape
3.1 Top Human Gene Therapy Players in Global Market
3.2 Top Global Human Gene Therapy Companies Ranked by Revenue
3.3 Global Human Gene Therapy Revenue by Companies
3.4 Global Human Gene Therapy Sales by Companies
3.5 Global Human Gene Therapy Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Gene Therapy Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Human Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Gene Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Gene Therapy Market Size Markets, 2022 & 2029
4.1.2 Non-viral Vectors
4.1.3 Viral Vectors
4.2 By Type - Global Human Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Human Gene Therapy Revenue, 2018-2023
4.2.2 By Type - Global Human Gene Therapy Revenue, 2024-2029
4.2.3 By Type - Global Human Gene Therapy Revenue Market Share, 2018-2029
4.3 By Type - Global Human Gene Therapy Sales & Forecasts
4.3.1 By Type - Global Human Gene Therapy Sales, 2018-2023
4.3.2 By Type - Global Human Gene Therapy Sales, 2024-2029
4.3.3 By Type - Global Human Gene Therapy Sales Market Share, 2018-2029
4.4 By Type - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Gene Therapy Market Size, 2022 & 2029
5.1.2 Neurological Diseases
5.1.3 Cancer
5.1.4 DMD (Duchenne Muscular Dystrophy)
5.1.5 Hepatological Diseases
5.1.6 Others
5.2 By Application - Global Human Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Human Gene Therapy Revenue, 2018-2023
5.2.2 By Application - Global Human Gene Therapy Revenue, 2024-2029
5.2.3 By Application - Global Human Gene Therapy Revenue Market Share, 2018-2029
5.3 By Application - Global Human Gene Therapy Sales & Forecasts
5.3.1 By Application - Global Human Gene Therapy Sales, 2018-2023
5.3.2 By Application - Global Human Gene Therapy Sales, 2024-2029
5.3.3 By Application - Global Human Gene Therapy Sales Market Share, 2018-2029
5.4 By Application - Global Human Gene Therapy Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Gene Therapy Market Size, 2022 & 2029
6.2 By Region - Global Human Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Human Gene Therapy Revenue, 2018-2023
6.2.2 By Region - Global Human Gene Therapy Revenue, 2024-2029
6.2.3 By Region - Global Human Gene Therapy Revenue Market Share, 2018-2029
6.3 By Region - Global Human Gene Therapy Sales & Forecasts
6.3.1 By Region - Global Human Gene Therapy Sales, 2018-2023
6.3.2 By Region - Global Human Gene Therapy Sales, 2024-2029
6.3.3 By Region - Global Human Gene Therapy Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Gene Therapy Revenue, 2018-2029
6.4.2 By Country - North America Human Gene Therapy Sales, 2018-2029
6.4.3 US Human Gene Therapy Market Size, 2018-2029
6.4.4 Canada Human Gene Therapy Market Size, 2018-2029
6.4.5 Mexico Human Gene Therapy Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Gene Therapy Revenue, 2018-2029
6.5.2 By Country - Europe Human Gene Therapy Sales, 2018-2029
6.5.3 Germany Human Gene Therapy Market Size, 2018-2029
6.5.4 France Human Gene Therapy Market Size, 2018-2029
6.5.5 U.K. Human Gene Therapy Market Size, 2018-2029
6.5.6 Italy Human Gene Therapy Market Size, 2018-2029
6.5.7 Russia Human Gene Therapy Market Size, 2018-2029
6.5.8 Nordic Countries Human Gene Therapy Market Size, 2018-2029
6.5.9 Benelux Human Gene Therapy Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Gene Therapy Revenue, 2018-2029
6.6.2 By Region - Asia Human Gene Therapy Sales, 2018-2029
6.6.3 China Human Gene Therapy Market Size, 2018-2029
6.6.4 Japan Human Gene Therapy Market Size, 2018-2029
6.6.5 South Korea Human Gene Therapy Market Size, 2018-2029
6.6.6 Southeast Asia Human Gene Therapy Market Size, 2018-2029
6.6.7 India Human Gene Therapy Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Gene Therapy Revenue, 2018-2029
6.7.2 By Country - South America Human Gene Therapy Sales, 2018-2029
6.7.3 Brazil Human Gene Therapy Market Size, 2018-2029
6.7.4 Argentina Human Gene Therapy Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Gene Therapy Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Gene Therapy Sales, 2018-2029
6.8.3 Turkey Human Gene Therapy Market Size, 2018-2029
6.8.4 Israel Human Gene Therapy Market Size, 2018-2029
6.8.5 Saudi Arabia Human Gene Therapy Market Size, 2018-2029
6.8.6 UAE Human Gene Therapy Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Human Gene Therapy Major Product Offerings
7.1.4 Biogen Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.1.5 Biogen Key News & Latest Developments
7.2 Sarepta Therapeutics
7.2.1 Sarepta Therapeutics Company Summary
7.2.2 Sarepta Therapeutics Business Overview
7.2.3 Sarepta Therapeutics Human Gene Therapy Major Product Offerings
7.2.4 Sarepta Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.2.5 Sarepta Therapeutics Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Human Gene Therapy Major Product Offerings
7.3.4 Gilead Sciences Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Amgen
7.4.1 Amgen Company Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Human Gene Therapy Major Product Offerings
7.4.4 Amgen Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.4.5 Amgen Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Human Gene Therapy Major Product Offerings
7.5.4 Novartis Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Orchard Therapeutics
7.6.1 Orchard Therapeutics Company Summary
7.6.2 Orchard Therapeutics Business Overview
7.6.3 Orchard Therapeutics Human Gene Therapy Major Product Offerings
7.6.4 Orchard Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.6.5 Orchard Therapeutics Key News & Latest Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Company Summary
7.7.2 Spark Therapeutics Business Overview
7.7.3 Spark Therapeutics Human Gene Therapy Major Product Offerings
7.7.4 Spark Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.7.5 Spark Therapeutics Key News & Latest Developments
7.8 Agc Biologics
7.8.1 Agc Biologics Company Summary
7.8.2 Agc Biologics Business Overview
7.8.3 Agc Biologics Human Gene Therapy Major Product Offerings
7.8.4 Agc Biologics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.8.5 Agc Biologics Key News & Latest Developments
7.9 Anges
7.9.1 Anges Company Summary
7.9.2 Anges Business Overview
7.9.3 Anges Human Gene Therapy Major Product Offerings
7.9.4 Anges Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.9.5 Anges Key News & Latest Developments
7.10 Bluebird Bio
7.10.1 Bluebird Bio Company Summary
7.10.2 Bluebird Bio Business Overview
7.10.3 Bluebird Bio Human Gene Therapy Major Product Offerings
7.10.4 Bluebird Bio Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.10.5 Bluebird Bio Key News & Latest Developments
7.11 Jazz Pharmaceuticals
7.11.1 Jazz Pharmaceuticals Company Summary
7.11.2 Jazz Pharmaceuticals Human Gene Therapy Business Overview
7.11.3 Jazz Pharmaceuticals Human Gene Therapy Major Product Offerings
7.11.4 Jazz Pharmaceuticals Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.11.5 Jazz Pharmaceuticals Key News & Latest Developments
7.12 Dynavax Technologies
7.12.1 Dynavax Technologies Company Summary
7.12.2 Dynavax Technologies Human Gene Therapy Business Overview
7.12.3 Dynavax Technologies Human Gene Therapy Major Product Offerings
7.12.4 Dynavax Technologies Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.12.5 Dynavax Technologies Key News & Latest Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Company Summary
7.13.2 Human Stem Cells Institute Human Gene Therapy Business Overview
7.13.3 Human Stem Cells Institute Human Gene Therapy Major Product Offerings
7.13.4 Human Stem Cells Institute Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.13.5 Human Stem Cells Institute Key News & Latest Developments
7.14 Sibiono Genetech
7.14.1 Sibiono Genetech Company Summary
7.14.2 Sibiono Genetech Business Overview
7.14.3 Sibiono Genetech Human Gene Therapy Major Product Offerings
7.14.4 Sibiono Genetech Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.14.5 Sibiono Genetech Key News & Latest Developments
7.15 Shanghai Sunway Biotech
7.15.1 Shanghai Sunway Biotech Company Summary
7.15.2 Shanghai Sunway Biotech Business Overview
7.15.3 Shanghai Sunway Biotech Human Gene Therapy Major Product Offerings
7.15.4 Shanghai Sunway Biotech Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.15.5 Shanghai Sunway Biotech Key News & Latest Developments
7.16 Uniqure N.V.
7.16.1 Uniqure N.V. Company Summary
7.16.2 Uniqure N.V. Business Overview
7.16.3 Uniqure N.V. Human Gene Therapy Major Product Offerings
7.16.4 Uniqure N.V. Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.16.5 Uniqure N.V. Key News & Latest Developments
7.17 Gensight Biologics S.A.
7.17.1 Gensight Biologics S.A. Company Summary
7.17.2 Gensight Biologics S.A. Business Overview
7.17.3 Gensight Biologics S.A. Human Gene Therapy Major Product Offerings
7.17.4 Gensight Biologics S.A. Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.17.5 Gensight Biologics S.A. Key News & Latest Developments
7.18 Celgene Corporation
7.18.1 Celgene Corporation Company Summary
7.18.2 Celgene Corporation Business Overview
7.18.3 Celgene Corporation Human Gene Therapy Major Product Offerings
7.18.4 Celgene Corporation Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.18.5 Celgene Corporation Key News & Latest Developments
7.19 Cellectis
7.19.1 Cellectis Company Summary
7.19.2 Cellectis Business Overview
7.19.3 Cellectis Human Gene Therapy Major Product Offerings
7.19.4 Cellectis Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.19.5 Cellectis Key News & Latest Developments
7.20 Sangamo Therapeutics
7.20.1 Sangamo Therapeutics Company Summary
7.20.2 Sangamo Therapeutics Business Overview
7.20.3 Sangamo Therapeutics Human Gene Therapy Major Product Offerings
7.20.4 Sangamo Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.20.5 Sangamo Therapeutics Key News & Latest Developments
7.21 Mustang Bio
7.21.1 Mustang Bio Company Summary
7.21.2 Mustang Bio Business Overview
7.21.3 Mustang Bio Human Gene Therapy Major Product Offerings
7.21.4 Mustang Bio Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.21.5 Mustang Bio Key News & Latest Developments
7.22 AGTC
7.22.1 AGTC Company Summary
7.22.2 AGTC Business Overview
7.22.3 AGTC Human Gene Therapy Major Product Offerings
7.22.4 AGTC Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.22.5 AGTC Key News & Latest Developments
7.23 Poseida Therapeutics
7.23.1 Poseida Therapeutics Company Summary
7.23.2 Poseida Therapeutics Business Overview
7.23.3 Poseida Therapeutics Human Gene Therapy Major Product Offerings
7.23.4 Poseida Therapeutics Human Gene Therapy Sales and Revenue in Global (2018-2023)
7.23.5 Poseida Therapeutics Key News & Latest Developments
8 Global Human Gene Therapy Production Capacity, Analysis
8.1 Global Human Gene Therapy Production Capacity, 2018-2029
8.2 Human Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Gene Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Gene Therapy Supply Chain Analysis
10.1 Human Gene Therapy Industry Value Chain
10.2 Human Gene Therapy Upstream Market
10.3 Human Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Gene Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Gene Therapy in Global Market
Table 2. Top Human Gene Therapy Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Gene Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Gene Therapy Revenue Share by Companies, 2018-2023
Table 5. Global Human Gene Therapy Sales by Companies, (K Units), 2018-2023
Table 6. Global Human Gene Therapy Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Gene Therapy Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Gene Therapy Product Type
Table 9. List of Global Tier 1 Human Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Gene Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Gene Therapy Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Gene Therapy Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Gene Therapy Sales (K Units), 2018-2023
Table 15. By Type - Global Human Gene Therapy Sales (K Units), 2024-2029
Table 16. By Application ? Global Human Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Gene Therapy Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Gene Therapy Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Gene Therapy Sales (K Units), 2018-2023
Table 20. By Application - Global Human Gene Therapy Sales (K Units), 2024-2029
Table 21. By Region ? Global Human Gene Therapy Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Gene Therapy Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Gene Therapy Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Gene Therapy Sales (K Units), 2018-2023
Table 25. By Region - Global Human Gene Therapy Sales (K Units), 2024-2029
Table 26. By Country - North America Human Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Gene Therapy Sales, (K Units), 2018-2023
Table 29. By Country - North America Human Gene Therapy Sales, (K Units), 2024-2029
Table 30. By Country - Europe Human Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Gene Therapy Sales, (K Units), 2018-2023
Table 33. By Country - Europe Human Gene Therapy Sales, (K Units), 2024-2029
Table 34. By Region - Asia Human Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Gene Therapy Sales, (K Units), 2018-2023
Table 37. By Region - Asia Human Gene Therapy Sales, (K Units), 2024-2029
Table 38. By Country - South America Human Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Gene Therapy Sales, (K Units), 2018-2023
Table 41. By Country - South America Human Gene Therapy Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Human Gene Therapy Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Gene Therapy Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Gene Therapy Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Gene Therapy Sales, (K Units), 2024-2029
Table 46. Biogen Company Summary
Table 47. Biogen Human Gene Therapy Product Offerings
Table 48. Biogen Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Biogen Key News & Latest Developments
Table 50. Sarepta Therapeutics Company Summary
Table 51. Sarepta Therapeutics Human Gene Therapy Product Offerings
Table 52. Sarepta Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Sarepta Therapeutics Key News & Latest Developments
Table 54. Gilead Sciences Company Summary
Table 55. Gilead Sciences Human Gene Therapy Product Offerings
Table 56. Gilead Sciences Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Gilead Sciences Key News & Latest Developments
Table 58. Amgen Company Summary
Table 59. Amgen Human Gene Therapy Product Offerings
Table 60. Amgen Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Amgen Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Human Gene Therapy Product Offerings
Table 64. Novartis Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Novartis Key News & Latest Developments
Table 66. Orchard Therapeutics Company Summary
Table 67. Orchard Therapeutics Human Gene Therapy Product Offerings
Table 68. Orchard Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Orchard Therapeutics Key News & Latest Developments
Table 70. Spark Therapeutics Company Summary
Table 71. Spark Therapeutics Human Gene Therapy Product Offerings
Table 72. Spark Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Spark Therapeutics Key News & Latest Developments
Table 74. Agc Biologics Company Summary
Table 75. Agc Biologics Human Gene Therapy Product Offerings
Table 76. Agc Biologics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Agc Biologics Key News & Latest Developments
Table 78. Anges Company Summary
Table 79. Anges Human Gene Therapy Product Offerings
Table 80. Anges Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Anges Key News & Latest Developments
Table 82. Bluebird Bio Company Summary
Table 83. Bluebird Bio Human Gene Therapy Product Offerings
Table 84. Bluebird Bio Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Bluebird Bio Key News & Latest Developments
Table 86. Jazz Pharmaceuticals Company Summary
Table 87. Jazz Pharmaceuticals Human Gene Therapy Product Offerings
Table 88. Jazz Pharmaceuticals Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Jazz Pharmaceuticals Key News & Latest Developments
Table 90. Dynavax Technologies Company Summary
Table 91. Dynavax Technologies Human Gene Therapy Product Offerings
Table 92. Dynavax Technologies Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Dynavax Technologies Key News & Latest Developments
Table 94. Human Stem Cells Institute Company Summary
Table 95. Human Stem Cells Institute Human Gene Therapy Product Offerings
Table 96. Human Stem Cells Institute Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Human Stem Cells Institute Key News & Latest Developments
Table 98. Sibiono Genetech Company Summary
Table 99. Sibiono Genetech Human Gene Therapy Product Offerings
Table 100. Sibiono Genetech Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Sibiono Genetech Key News & Latest Developments
Table 102. Shanghai Sunway Biotech Company Summary
Table 103. Shanghai Sunway Biotech Human Gene Therapy Product Offerings
Table 104. Shanghai Sunway Biotech Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Shanghai Sunway Biotech Key News & Latest Developments
Table 106. Uniqure N.V. Company Summary
Table 107. Uniqure N.V. Human Gene Therapy Product Offerings
Table 108. Uniqure N.V. Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Uniqure N.V. Key News & Latest Developments
Table 110. Gensight Biologics S.A. Company Summary
Table 111. Gensight Biologics S.A. Human Gene Therapy Product Offerings
Table 112. Gensight Biologics S.A. Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Gensight Biologics S.A. Key News & Latest Developments
Table 114. Celgene Corporation Company Summary
Table 115. Celgene Corporation Human Gene Therapy Product Offerings
Table 116. Celgene Corporation Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Celgene Corporation Key News & Latest Developments
Table 118. Cellectis Company Summary
Table 119. Cellectis Human Gene Therapy Product Offerings
Table 120. Cellectis Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Cellectis Key News & Latest Developments
Table 122. Sangamo Therapeutics Company Summary
Table 123. Sangamo Therapeutics Human Gene Therapy Product Offerings
Table 124. Sangamo Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Sangamo Therapeutics Key News & Latest Developments
Table 126. Mustang Bio Company Summary
Table 127. Mustang Bio Human Gene Therapy Product Offerings
Table 128. Mustang Bio Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 129. Mustang Bio Key News & Latest Developments
Table 130. AGTC Company Summary
Table 131. AGTC Human Gene Therapy Product Offerings
Table 132. AGTC Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 133. AGTC Key News & Latest Developments
Table 134. Poseida Therapeutics Company Summary
Table 135. Poseida Therapeutics Human Gene Therapy Product Offerings
Table 136. Poseida Therapeutics Human Gene Therapy Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 137. Poseida Therapeutics Key News & Latest Developments
Table 138. Human Gene Therapy Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 139. Global Human Gene Therapy Capacity Market Share of Key Manufacturers, 2021-2023
Table 140. Global Human Gene Therapy Production by Region, 2018-2023 (K Units)
Table 141. Global Human Gene Therapy Production by Region, 2024-2029 (K Units)
Table 142. Human Gene Therapy Market Opportunities & Trends in Global Market
Table 143. Human Gene Therapy Market Drivers in Global Market
Table 144. Human Gene Therapy Market Restraints in Global Market
Table 145. Human Gene Therapy Raw Materials
Table 146. Human Gene Therapy Raw Materials Suppliers in Global Market
Table 147. Typical Human Gene Therapy Downstream
Table 148. Human Gene Therapy Downstream Clients in Global Market
Table 149. Human Gene Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Gene Therapy Segment by Type in 2022
Figure 2. Human Gene Therapy Segment by Application in 2022
Figure 3. Global Human Gene Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Gene Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Gene Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Gene Therapy Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Gene Therapy Revenue in 2022
Figure 9. By Type - Global Human Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Gene Therapy Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Gene Therapy Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Gene Therapy Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Human Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Gene Therapy Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Gene Therapy Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Gene Therapy Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Human Gene Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Gene Therapy Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Gene Therapy Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Gene Therapy Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Gene Therapy Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Gene Therapy Sales Market Share, 2018-2029
Figure 23. US Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Gene Therapy Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Gene Therapy Sales Market Share, 2018-2029
Figure 28. Germany Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Gene Therapy Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Gene Therapy Sales Market Share, 2018-2029
Figure 37. China Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Gene Therapy Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Gene Therapy Sales Market Share, 2018-2029
Figure 44. Brazil Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Gene Therapy Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Gene Therapy Sales Market Share, 2018-2029
Figure 48. Turkey Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Gene Therapy Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Gene Therapy Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Human Gene Therapy by Region, 2022 VS 2029
Figure 54. Human Gene Therapy Industry Value Chain
Figure 55. Marketing Channels
